Myriad Genetics Inc. (MYGN) reported first quarter EPS of $0.41 after the close Tuesday, up from $0.25 in the previous year. Analysts expected EPS of $0.35. The company expects to report second quarter EPS of $0.40 to $0.42 and between $1.60 and $1.65. The consensus estimates are for EPS of $0.42 and $1.64.
Myriad Genetics gapped up at the open Tuesday and climbed for the bulk of the afternoon. Shares finished up by 3.84 at $46.16 on above average volume. The stock broke out of a 2-week trading range and set a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News